Camille Mojica Rey

ARTICLES BY CAMILLE MOJICA REY

• Connecting Women Who Are Boardroom Ready

  4/1/2019

  The inside scoop on a program designed for women seeking board positions at biopharma companies. It’s more than just training; it’s networking assistance that is the real value.

• Doug Given: From Pharma To Redefining Healthcare

  3/1/2019

  A retired pharma executive decides to tackle the daunting task of revamping the U.S. healthcare system.

• The Unique Challenges Facing Cannabis-based Pharma

  1/2/2019

  Now that the FDA has finally approved the first-ever pharmaceutical derived from the cannabis plant, will drug development — and success — in this niche finally take off?

• Big Pharma’s Unique Approaches To Leadership Development

  1/2/2019

  To ensure that future leaders will be up to the challenges they will face, pharma companies are pursuing unique programs focused on problem-solving — sometimes sending employees to developing countries where they must tackle real-world problems.

• MD’s I270 Biotech Corridor: A Hub Within A Hub

  11/7/2018

  The larger BioHealth Capital Region, of which the I-270 biotech corridor is a part, currently ranks as the fifth largest biotech hub in the U.S. with 39,000 people employed by the industry.

• Biopharma Pioneer Returns To Small Company Roots

  10/4/2018

  When Celgene began pursuing an aggressive acquisition strategy, David Stirling, Ph.D., a cofounder, decided to leave and eventually start his own company, BioTheryX.

• Why And How To Close The Gender Gap In The Life Sciences

  9/3/2018

  Women in leadership roles in the biopharma industry say it is imperative that the industry’s gender gap problem be addressed — by both men and women. Because, if the current trend of women leaving the industry continues, this problem will become a worker-shortage problem and reduce innovation that is vital for industry growth.

• From Big Pharma To Small Company Founder

  9/3/2018

  Don DeGolyer talks about the process he took to go from working at a Big Pharma like Sandoz to founding and running his own small specialty pharma company.

• Biopharma Startups Seek Big Pharma Expertise

  8/2/2018

  Former Big Pharma employees are helping startups go further in the drug development process, and in return, small companies are offering those with Big Pharma experience a chance to see what it’s like to have a large impact on the trajectory of a small company.

• Being A Multicultural Millennial Female In Pharma Manufacturing

  6/1/2018

  Tawni Koutchesfahani, director of manufacturing strategy at Relypsa, says pharmaceutical manufacturing must diversify if it is to thrive. That means the recruitment and retention of more women and more millennials.

• Biopharma Startups Take Advantage Of Open IPO Window

  6/1/2018

  Biopharma startups are enjoying a window of opportunity for successful IPOs that opened in mid-2017. CEOs share their experiences of going public, what is fueling IPOs, and tips for others thinking about making this important next step.

• J&J’s QuickFire Challenges: Crowdsourcing Innovation

  5/2/2018

  An in-depth look at J&J’s QuickFire Challenge program and how some of the winners have benefitted (and grown) beyond the cash grants.

• Pharmas That Build Unique Corporate Cultures

  4/6/2018

  Creating unique cultures that motivate your inherently diverse teams for the long haul to FDA approval is the secret to recruitment and retention in pharma where competition for highly skilled workers is fierce. It is also the key to achieving high performance and employee satisfaction.

• The Art Of Leadership

  2/7/2018

  Former Pfizer exec and current partner at VC firm Polaris Partners Amy Schulman talks about what it takes to lead a pharma startup.

• One Small Startup’s Quest For Funding Gets Creative

  1/9/2018

  As CEO of Ensysce Biosciences, a semi-virtual company with three employees, Lynn Kirkpatrick, Ph.D., knows all about the funding struggles of a small company.

• Will Value-Based Drug Pricing Work?

  11/8/2017

  Drug companies have begun experimenting with value-based models, largely in response to public outrage over the cost of prescription drugs and the U.S. government’s efforts to rein in those costs.

• Value-Based Healthcare: Pharma’s Role In The Transition

  10/10/2017

  This is the first in a two-part series on value-based healthcare. In Part II, Life Science Leader will look at value-based models used to determine the price of drugs.

• Diversification Relieves Funding Pressure For Small Pharma

  10/10/2017

  Chronic pressure is a way of life for those starting pharmaceutical companies. It’s a life filled with rounds of funding, investor demands, performance deadlines, and possible compound failures. But what if the technology owned by a startup drug discovery company was suddenly in demand by some of the world’s largest food and beverage corporations? What if that opportunity gives you the flexibility and time to conduct your research on your own timetable?

• Preparing For A Blockchain-Enabled World

  9/8/2017

  Ask life sciences industry leaders and experts about blockchain and you will hear it called everything from “a game changer” to “a major disrupter.” According to the hype, the technology behind cryptocurrencies, like bitcoin, is going to completely transform day-to-day operations for life sciences companies.

• New Hampshire: A Biotech Microhub

  8/9/2017

  As the biotech sector in the U.S. continues to grow, it is doing so not just in hubs, but in smaller places like New Hampshire — where some of the state’s biopharma entrepreneurs say: “Smaller is better.”